Strategic Partnerships MEGIN is actively expanding through collaborations with prestigious academic and research institutions (Tsinghua University, Aalto University) and startup partners (FIND Neuro). This signals ongoing opportunities to position MEG technology within joint research programs, grant-funded studies, and translational projects in neuroscience and clinical care.

Global Expansion With a global footprint spanning Finland, the UK, the USA, and Japan, MEGIN is positioned to pursue multi-region sales initiatives, local partnerships, and service agreements to support installed base growth and cross-border trials, especially in leading neuroscience hubs.

Clinical Adoption MEGIN emphasizes translating research into accessible clinical solutions and improving brain health outcomes, creating a sales path focused on hospital systems, neuroimaging centers, and patient-care networks seeking to elevate diagnostic capabilities and patient throughput with MEG technology.

Hyperscanning Opportunity Recent launch of side-by-side dual-MEG hyperscanning facilities presents a compelling use case for collaborative studies and multi-subject research, opening opportunities to target research consortia, large-scale cognitive neuroscience projects, and grants that require hyperscanning capabilities.

Mid-market Growth Revenue range and employee size indicate a mid-market company with potential for upsell of hardware upgrades, analytics software, maintenance contracts, and training services to hospitals and research centers looking to scale MEG deployments and maximize existing investments.